Chondros Dimitrios 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Aug 5, 2019
Insider Transaction Report
Form 4
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2019-08-03$16.70/sh−1,328$22,178→ 38,584 total
Footnotes (1)
- [F1]The reported disposition of 1,328 shares represents the shares that were sold by the reporting person to cover minimum statutory obligations due upon vesting of 3,750 restricted stock award shares.